Product Code: ETC13230718 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Aneurysm Market was valued at USD 8.7 Billion in 2024 and is expected to reach USD 16.4 Billion by 2031, growing at a compound annual growth rate of 10.30% during the forecast period (2025-2031).
The Global Aneurysm Market is witnessing significant growth driven by the increasing prevalence of aneurysms worldwide, particularly in aging populations. Aneurysms, which are characterized by the weakening and bulging of blood vessel walls, pose a serious health risk if left untreated, leading to potentially fatal complications such as ruptures. The market is fueled by advancements in minimally invasive treatment options such as endovascular coiling and flow diversion devices, which offer safer and more effective alternatives to traditional surgical interventions. Key players in the market are investing in research and development to innovate new technologies and devices for the treatment of aneurysms, enhancing patient outcomes and reducing treatment risks. Additionally, rising healthcare expenditure and improving healthcare infrastructure in emerging economies are expected to drive market growth in the coming years.
The global aneurysm market is witnessing a shift towards minimally invasive treatment options such as endovascular coiling and flow diversion devices, driven by advancements in technology and increasing demand for quicker recovery times. The market is also experiencing growth due to the rising prevalence of aneurysms, particularly in aging populations, as well as improved awareness and diagnosis rates. Opportunities lie in the development of innovative therapies and devices that offer improved efficacy and safety profiles, as well as in expanding into emerging markets with unmet medical needs. Additionally, collaborations between industry players and healthcare providers to enhance patient outcomes and reduce treatment costs are becoming increasingly important in this competitive landscape.
The Global Aneurysm Market faces several challenges, including limited awareness about aneurysms among the general population, leading to underdiagnosis and undertreatment of the condition. Additionally, the high cost of treatment options such as surgical intervention and endovascular procedures poses a financial burden on patients and healthcare systems. There is also a lack of standardized guidelines for the management of aneurysms, resulting in variability in treatment approaches and outcomes. Furthermore, the increasing prevalence of risk factors such as hypertension and smoking contributes to the growing burden of aneurysm cases worldwide. Addressing these challenges requires improved education and awareness campaigns, innovative and cost-effective treatment options, as well as collaborative efforts among healthcare providers, researchers, and policymakers to optimize patient care and outcomes in the Global Aneurysm Market.
The global aneurysm market is primarily driven by the increasing prevalence of aneurysms worldwide, particularly in aging populations. Technological advancements in imaging techniques and minimally invasive procedures have improved the diagnosis and treatment of aneurysms, leading to a growing demand for these services. Additionally, the rising awareness about the importance of early detection and treatment of aneurysms among both healthcare professionals and patients is driving market growth. Government initiatives and healthcare policies aimed at improving the management of aneurysms are also contributing to the expansion of the market. Furthermore, the increasing healthcare expenditure and investments in research and development activities focused on innovative treatment options are expected to further propel the growth of the global aneurysm market.
Government policies related to the Global Aneurysm Market typically focus on improving access to healthcare services, promoting research and development of innovative treatments, and ensuring patient safety. Governments may implement regulations to streamline the approval process for new aneurysm treatments, invest in public health programs to raise awareness about aneurysm prevention, and provide funding for research initiatives aimed at advancing the understanding of aneurysm causes and treatments. Additionally, governments often work to establish guidelines for healthcare providers to ensure high-quality care for aneurysm patients and monitor outcomes to improve overall healthcare system efficiency. Overall, government policies play a crucial role in shaping the landscape of the Global Aneurysm Market by driving innovation, improving patient outcomes, and enhancing access to care.
The Global Aneurysm Market is expected to witness significant growth in the coming years due to the increasing prevalence of aneurysms, advancements in medical technology for diagnosis and treatment, and a growing aging population. Technological innovations such as minimally invasive procedures and the development of novel therapies are anticipated to drive market expansion. Additionally, rising awareness about aneurysm risks and the availability of better healthcare infrastructure in developing countries are likely to contribute to market growth. However, challenges such as high treatment costs, limited access to specialized healthcare services in some regions, and the potential risks associated with certain treatment options may hinder market progression. Overall, the Global Aneurysm Market is poised for steady growth, fueled by technological advancements and increasing healthcare investments.
In the global aneurysm market, Asia is expected to witness significant growth due to the rising prevalence of risk factors such as hypertension and smoking. North America is anticipated to dominate the market, driven by advanced healthcare infrastructure and a high prevalence of lifestyle-related diseases. Europe is also a key market, with a focus on technological advancements and increasing awareness about aneurysm treatment options. The Middle East and Africa region is projected to experience steady growth, supported by improving healthcare facilities and rising investments in healthcare infrastructure. Latin America is poised for growth due to increasing healthcare expenditure and a growing patient population. Overall, the global aneurysm market is characterized by ongoing research and development activities, strategic collaborations, and a focus on innovative treatment approaches.
Global Aneurysm Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Aneurysm Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Aneurysm Market Revenues & Volume, 2021 & 2031F |
3.3 Global Aneurysm Market - Industry Life Cycle |
3.4 Global Aneurysm Market - Porter's Five Forces |
3.5 Global Aneurysm Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Aneurysm Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Aneurysm Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Global Aneurysm Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Global Aneurysm Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Global Aneurysm Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Aneurysm Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Aneurysm Market Trends |
6 Global Aneurysm Market, 2021 - 2031 |
6.1 Global Aneurysm Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Aneurysm Market, Revenues & Volume, By Ruptured Aneurysm, 2021 - 2031 |
6.1.3 Global Aneurysm Market, Revenues & Volume, By Leaking Aneurysm, 2021 - 2031 |
6.1.4 Global Aneurysm Market, Revenues & Volume, By Unruptured Aneurysm, 2021 - 2031 |
6.1.5 Global Aneurysm Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Aneurysm Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Aneurysm Market, Revenues & Volume, By Surgery, 2021 - 2031 |
6.2.3 Global Aneurysm Market, Revenues & Volume, By Medication, 2021 - 2031 |
6.2.4 Global Aneurysm Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Aneurysm Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Aneurysm Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.3.3 Global Aneurysm Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.3.4 Global Aneurysm Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Aneurysm Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Aneurysm Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Aneurysm Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.4.4 Global Aneurysm Market, Revenues & Volume, By Speciality Centres, 2021 - 2031 |
6.4.5 Global Aneurysm Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global Aneurysm Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Aneurysm Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.5.3 Global Aneurysm Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
6.5.4 Global Aneurysm Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
7 North America Aneurysm Market, Overview & Analysis |
7.1 North America Aneurysm Market Revenues & Volume, 2021 - 2031 |
7.2 North America Aneurysm Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Aneurysm Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Aneurysm Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Aneurysm Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Aneurysm Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Aneurysm Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.5 North America Aneurysm Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6 North America Aneurysm Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.7 North America Aneurysm Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Aneurysm Market, Overview & Analysis |
8.1 Latin America (LATAM) Aneurysm Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Aneurysm Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Aneurysm Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Aneurysm Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Aneurysm Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Aneurysm Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Aneurysm Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Aneurysm Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.5 Latin America (LATAM) Aneurysm Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.6 Latin America (LATAM) Aneurysm Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8.7 Latin America (LATAM) Aneurysm Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Aneurysm Market, Overview & Analysis |
9.1 Asia Aneurysm Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Aneurysm Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Aneurysm Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Aneurysm Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Aneurysm Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Aneurysm Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Aneurysm Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Aneurysm Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.5 Asia Aneurysm Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.6 Asia Aneurysm Market, Revenues & Volume, By End-Users, 2021 - 2031 |
9.7 Asia Aneurysm Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Aneurysm Market, Overview & Analysis |
10.1 Africa Aneurysm Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Aneurysm Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Aneurysm Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Aneurysm Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Aneurysm Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Aneurysm Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Aneurysm Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Aneurysm Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.5 Africa Aneurysm Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.6 Africa Aneurysm Market, Revenues & Volume, By End-Users, 2021 - 2031 |
10.7 Africa Aneurysm Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Aneurysm Market, Overview & Analysis |
11.1 Europe Aneurysm Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Aneurysm Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Aneurysm Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Aneurysm Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Aneurysm Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Aneurysm Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Aneurysm Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Aneurysm Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.5 Europe Aneurysm Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.6 Europe Aneurysm Market, Revenues & Volume, By End-Users, 2021 - 2031 |
11.7 Europe Aneurysm Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Aneurysm Market, Overview & Analysis |
12.1 Middle East Aneurysm Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Aneurysm Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Aneurysm Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Aneurysm Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Aneurysm Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Aneurysm Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Aneurysm Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.5 Middle East Aneurysm Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.6 Middle East Aneurysm Market, Revenues & Volume, By End-Users, 2021 - 2031 |
12.7 Middle East Aneurysm Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Aneurysm Market Key Performance Indicators |
14 Global Aneurysm Market - Export/Import By Countries Assessment |
15 Global Aneurysm Market - Opportunity Assessment |
15.1 Global Aneurysm Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Aneurysm Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Aneurysm Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.4 Global Aneurysm Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.5 Global Aneurysm Market Opportunity Assessment, By End-Users, 2021 & 2031F |
15.6 Global Aneurysm Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Aneurysm Market - Competitive Landscape |
16.1 Global Aneurysm Market Revenue Share, By Companies, 2024 |
16.2 Global Aneurysm Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |